Background Statins are a class of medications that reduce cholesterol by inhibiting 3-
hydroxy-3-methylglutaryl-coenzyme A reductase. Whether statins can benefit patients with …

Background Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) reduce
cardiovascular risk through mechanisms that might affect the development of dementia …

Background Studies demonstrate the potential for statins to prevent dementia and
Alzheimer's disease (AD), but the evidence is inconclusive. Objective Conduct a meta …

Abstract Background and Aims: The impact of statin on dementia risk reduction has been a
subject of debate over the last decade, but the evidence remains inconclusive. Therefore …

Previous studies have indicated that statins use is associated with risk of dementia, but
presented controversial results. Medline, Embase, Web of Science, and the Cochrane …

Abstract Background/Aim: 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
(statins) are thought to reduce the amount of Abeta peptides by reducing cholesterol from …

Background. Previous evidence suggests that treatment with 3-hydroxy-3-methylglutaryl-
coenzyme-A reductase inhibitors (statins) has a positive impact on dementia. We decided to …

Introduction Establishing efficacy of and molecular pathways for statins has the potential to
impact incidence of Alzheimer's and age‐related neurodegenerative diseases (NDD) …

We conducted a systematic review and meta-analysis to investigate whether the use of
statins could be associated with the risk of all-caused dementia, Alzheimer's disease (AD) …

Importance To our knowledge, no effective treatments exist for Alzheimer disease, and new
molecules are years away. However, several drugs prescribed for other conditions have …